APP and Alzheimer disease: PGZ was also found to normalize p35 protein and CRMP2 levels in the cerebellum, with the improvement of coordination and long-term depression in APP/PS1 mice [134], suggesting PGZ as a prophylactic to be used at the pre-Aβ accumulation stage in AD model mice.